Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEco Animal Regulatory News (EAH)

Share Price Information for Eco Animal (EAH)

Share Price is delayed by 15 minutes
Get Live Data
88.00    -0.50 (-0.56%)
Bid:
87.00
Ask:
89.00
Spread: 2.00 (2.299%)
Market Cap: £59.03m
EAH Live PriceLast checked at - London Stock Exchange

Intraday Eco Animal Share Chart

R&D Day

13 Mar 2025 07:00

RNS Number : 4590A
Eco Animal Health Group PLC
13 March 2025
 

13 March 2025

 

 

 

ECO Animal Health Group plc

("ECO" or the "Company")

 

R&D Day

ECO Animal Health Group plc (AIM: EAH), a rapidly growing global animal health company with a portfolio of marketed veterinary products and a maturing proprietary R&D pipeline, announces that it is hosting an R&D Day today for institutional and private investors and analysts, with presentations starting at 2:00pm GMT at Andaz London, 40 Liverpool St, London EC2M 7QN.

The event will be led by David Hallas, CEO, and Chris Wilks, CFO, alongside senior leaders from across the Company and an industry expert. Attendees will have the opportunity to gain valuable insights on how the next generation of assets in ECO's R&D pipeline are driving long-term value creation and future proofing the business through innovations in preventative animal health.

For those who would like to join virtually, please register via the dedicated registration page: https://www.equitydevelopment.co.uk/news-and-events/eah-rd-investor-presentation-13march2025.

No new information will be provided on current trading at the R&D Day. For guidance on FY25 trading, the Company asks investors to review the outlook section of the interim results announced on 28 November 2024 as this remains relevant. The Company will provide a trading update for the year ending 31 March 2025 in April 2025.

 

Following the event, slides and a recording will be made available for viewing on the Investors section of the Company's website.

 

 

 

-Ends-

For further information please contact:

ECO Animal Health Group plc

David Hallas (CEO)

Christopher Wilks (CFO)

020 8447 8899

 

Singer Capital Markets (Nominated Adviser & Joint Broker)

Phil Davies

Sam Butcher

020 7496 3000

Investec (Joint Broker)

Gary Clarence

Lydia Zychowska

020 7597 5970

 

 

Equity Development

Hannah Crowe

Matt Evans

020 7065 2692

ICR Healthcare (Financial PR)

Mary-Jane Elliott

Jessica Hodgson

020 3709 5700

ecoanimalhealth@consilium-comms.com

About ECO Animal Health

ECO Animal Health is a world leader in animal health, developing and marketing branded veterinary pharmaceuticals globally, with expertise in antibiotics and vaccines for pigs and poultry. We have a maturing proprietary R&D pipeline.

Headquartered in the UK, with global offices including R&D and manufacturing, we have marketing authorisations in over 70 countries and employ over 200 people worldwide.

Our lead product, Aivlosin® is a proprietary, patented medication which is effective against both respiratory and intestinal diseases in pigs and poultry. 

Click here for more information: https://ecoanimalhealth.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCKZGMFLZLGKZM
Date   Source Headline
25th Aug 20152:41 pmBUSTransaction in Own Shares
29th Jul 20158:55 amBUSDirector/PDMR Shareholding
28th Jul 20159:23 amBUSDirector/PDMR Shareholding
17th Jul 20154:01 pmBUSDirector/PDMR Shareholding
3rd Jul 20153:23 pmBUSCirc re.Posting of Annual Report and Notice of Meeting
3rd Jul 20157:00 amBUSFinal Results
11th Jun 201511:36 amBUSTransaction in Own Shares
11th May 20157:00 amBUSRegulatory Approval
23rd Apr 20154:57 pmBUSBlock Listing Application
23rd Apr 20153:04 pmBUSTransaction in Own Shares
15th Apr 201512:12 pmBUSIssue of Equity
14th Apr 201511:47 amBUSIssue of Equity
13th Apr 20157:00 amBUSTrading Statement
17th Mar 201510:50 amBUSTransaction in Own Shares
11th Mar 20153:43 pmBUSDirector/PDMR Shareholding - Replacement
2nd Mar 20159:37 amBUSIssue of Equity
26th Feb 20159:19 amBUSIssue of Equity
23rd Feb 20155:00 pmBUSHolding(s) in Company
18th Feb 20159:20 amBUSDirector/PDMR Shareholding
12th Feb 20153:24 pmBUSCirc re.Share buy-back programme
26th Jan 20152:03 pmBUSIssue of Equity
22nd Jan 201510:56 amBUSDirector/PDMR Shareholding
21st Jan 20159:22 amBUSHolding(s) in Company
13th Jan 20154:54 pmBUSIssue of Equity
22nd Dec 20141:26 pmBUSDirectorate Change
3rd Dec 20147:00 amBUSHalf-yearly Report
31st Oct 20149:18 amBUSHolding(s) in Company
18th Sep 201411:07 amBUSResult of AGM
29th Aug 201410:35 amBUSDirector/PDMR Shareholding
30th Jul 201410:24 amBUSCirc re.Posting of Annual Report and Notice of Meeting
28th Jul 20147:00 amBUSFinal Results
10th Jun 20147:00 amBUSChange of Nomad
13th Mar 20149:50 amBUSIssue of Equity
25th Feb 20149:06 amBUSRegulatory Approval
25th Feb 20147:00 amBUSRegulatory Application
3rd Feb 20147:00 amBUSRegulatory Approval
28th Jan 201412:45 pmBUSHolding(s) in Company
27th Jan 20147:00 amBUSRegulatory Approval
10th Dec 20137:00 amBUSHalf-yearly Report
2nd Dec 20137:00 amBUSRegulatory Approval
28th Nov 201310:23 amBUSIssue of Equity
28th Nov 20139:22 amBUSHolding(s) in Company
28th Oct 20137:00 amBUSRegulatory Approval
25th Oct 20133:03 pmBUSHolding(s) in Company
24th Oct 20133:04 pmBUSHolding(s) in Company
24th Oct 20132:57 pmBUSIssue of Equity
22nd Oct 20133:03 pmBUSResult of EGM
15th Oct 20131:29 pmBUSCirc re.Issue of Options
3rd Oct 20139:33 amBUSIssue of Equity
25th Sep 201312:38 pmBUSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.